A Mn(III)-Sealed Metal–Organic Framework Nanosystem for Redox-Unlocked Tumor Theranostics
Source abstract
Abstract
Here, a Mn(III)-sealed metal-organic framework (MOF) nanosystem based on coordination between Mn(III) and porphyrin (TCPP) via a one-pot method was designed and constructed. Mn(III), as a sealer, not only quenched TCPP-based fluorescence but also inhibited reactive oxygen species (ROS) generation, which made MOFs an "inert" theranostic nanoparticle. Interestingly, upon endocytosis by tumor cells, MOFs were disintegrated into Mn(II) and free TCPP by intracellular glutathione (GSH) in tumor cells, owing to redox reaction between Mn(III) and GSH. This disintegration would lead to consumption of antioxidant GSH and activated Mn(II)-based magnetic resonance imaging (MRI) as well as TCPP-based fluorescent imaging. More importantly, such a GSH-regulated TCPP release could implement controllable ROS generation under irradiation, which avoided side effects (inflammation and damage of normal tissues). As a consequence, after unlocking by GSH, Mn(III)-sealed MOFs could significantly improve the therapeutic efficiency of photodynamic therapy by combining controlled ROS generation and GSH depletion after precise dual tumor homing.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Metal-Organic Frameworks: Synthesis and Applications · Luminescence and Fluorescent Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Key Laboratory of Biomedical Polymers of Ministry of Education & Department of Chemistry, the Institute for Advanced Studies, Wuhan University, Wuhan 430072, People’s Republic of China
Funding
National Natural Science Foundation of China
References (35)
Show source-provided references
1. 10.1021/acsnano.7b0862810.1021/acsnano.7b08628 ↗
2. 10.1016/j.biomaterials.2018.09.00410.1016/j.biomaterials.2018.09.004 ↗
3. 10.1016/j.isci.2018.10.00510.1016/j.isci.2018.10.005 ↗
4. 10.1038/nrc107110.1038/nrc1071 ↗
5. 10.1002/ange.20190281010.1002/ange.201902810 ↗
6. 10.1021/ja508679h10.1021/ja508679h ↗
7. 10.1039/C6CS00458J10.1039/C6CS00458J ↗
8. 10.1038/nature0773310.1038/nature07733 ↗
9. 10.1016/j.canlet.2012.09.01210.1016/j.canlet.2012.09.012 ↗
10. 10.1021/jacs.7b1111410.1021/jacs.7b11114 ↗
11. 10.1002/adma.20180820010.1002/adma.201808200 ↗
12. 10.1021/acsnano.8b0118610.1021/acsnano.8b01186 ↗
13. 10.1038/nrc189410.1038/nrc1894 ↗
14. 10.1021/acs.chemrev.5b0012510.1021/acs.chemrev.5b00125 ↗
15. 10.1016/j.mtchem.2018.06.00310.1016/j.mtchem.2018.06.003 ↗
16. 10.1021/acscentsci.8b0082210.1021/acscentsci.8b00822 ↗
17. 10.1002/advs.20180028710.1002/advs.201800287 ↗
18. 10.1016/j.biomaterials.2016.05.02710.1016/j.biomaterials.2016.05.027 ↗
19. 10.1021/jacs.6b0000710.1021/jacs.6b00007 ↗
20. 10.1002/anie.20171080010.1002/anie.201710800 ↗
21. 10.1002/anie.20170800510.1002/anie.201708005 ↗
22. 10.1038/s41467-018-06655-710.1038/s41467-018-06655-7 ↗
23. 10.1021/nn505989e10.1021/nn505989e ↗
24. 10.1002/adma.20170756710.1002/adma.201707567 ↗
25. 10.1002/adfm.20180380410.1002/adfm.201803804 ↗
26. 10.1002/adfm.20170545110.1002/adfm.201705451 ↗
27. 10.1021/acsami.8b0968010.1021/acsami.8b09680 ↗
28. 10.1016/j.apsusc.2010.10.05110.1016/j.apsusc.2010.10.051 ↗
29. 10.1021/jacs.6b1078110.1021/jacs.6b10781 ↗
30. 10.1021/ja210077410.1021/ja2100774 ↗
31. 10.1021/acs.est.8b0399310.1021/acs.est.8b03993 ↗
32. 10.1002/anie.20180137810.1002/anie.201801378 ↗
33. 10.1021/nn506640h10.1021/nn506640h ↗
34. 10.1002/ange.20171202710.1002/ange.201712027 ↗
35. 10.1002/ange.20170315910.1002/ange.201703159 ↗